Iovance Biotherapeutics (IOVA) Change in Inventory (2023 - 2026)

Iovance Biotherapeutics (IOVA) has reported Change in Inventory for 4 consecutive years, with $4.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Inventory fell 64.36% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $5.3 million (down 89.69% YoY), while the FY2025 annual figure was $14.2 million, down 67.98% from the prior year.
• Change in Inventory grew to $4.9 million in Q1 2026 per IOVA's latest filing, from $4.0 million in the prior quarter.
• Across five years, Change in Inventory topped out at $18.9 million in Q4 2024 and bottomed at -$6.8 million in Q2 2025.
• Historically, Change in Inventory has averaged $6.1 million across 4 years, with a median of $5.8 million in 2024.
• Annual changes were most pronounced in 2024 — Change in Inventory soared 2885.59% — and 2025, when it sank 176.83%.
• Iovance Biotherapeutics' Change in Inventory stood at $923000.0 in 2023, then surged by 1950.6% to $18.9 million in 2024, then plunged by 78.86% to $4.0 million in 2025, then rose by 23.24% to $4.9 million in 2026.
• Business Quant data shows IOVA's Change in Inventory at $4.9 million in Q1 2026, $4.0 million in Q4 2025, and $3.2 million in Q3 2025.